Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 1,600 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Pain
Interventions: Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine), Placebo Patch; Drug
Lead sponsor: ZARS Pharma Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: San Diego, California

Conditions: Motion Sickness
Interventions: scopolamine HBr, Transdermal Scopolamine; Drug
Lead sponsor: Repurposed Therapeutics, Inc.; Industry
Eligibility: 18 Years to 59 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Smoking, Anxiety Disorders, Depression Disorders
Interventions: Nicotine Patch, Depression and Anxiety Smoking Cessation Treatment, Educational-Support Psychotherapy; Drug · Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Decompensated Heart Failure
Interventions: AVIVO™ PiiX Patch Monitor System; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 7
States / cities: La Jolla, California • Tampa, Florida • Saint Paul, Minnesota + 4 more

Conditions: Suicidal Ideation
Interventions: Estradiol Transdermal Patch 0.1 mg/24 hrs, Oral Micronized Progesterone, Inactive Clear Patch, Placebo capsule; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Smoking Cessation
Interventions: Tobacco Tactics Intervention, Usual Care; Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1,528 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 6
States / cities: Grand Rapids, Michigan • Livonia, Michigan • Muskegon, Michigan + 2 more

Conditions: Lagophthalmos
Interventions: Tarsus Patch; Device
Lead sponsor: Angeline Nguyen; Other
Eligibility: Up to 17 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Nicotine Dependence
Interventions: Juul Electronic cigarette, Very Low Nicotine Cigarettes, Active Nicotine Patch, Placebo Patch; Device · Other · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years and older
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Pigmented Skin Lesion
Interventions: Dermal Cooling System; Device
Lead sponsor: R2 Dermatology; Industry
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Smoking Cessation, Cancer
Interventions: Transdermal Nicotine Patch, Standard Telephone Counseling, Varenicline, Cancer-Targeted Telephone Counseling, Mailed Information about Standard Care Resources; Drug · Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Testosterone Transdermal System, Placebo patch; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 1,271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 115
States / cities: Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 97 more

Conditions: Attention Deficit Hyperactivity Disorder, INSOMNIA
Interventions: Daytrana; Drug
Lead sponsor: Cox Health Systems; Other
Eligibility: 6 Years to 12 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Turner Syndrome, Primary Ovarian Insufficiency
Interventions: Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch; Drug
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 12 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Basal Cell Carcinoma
Interventions: Optical Coherence Tomography (OCT), Curettage & Desiccation (C&D) Procedure; Device · Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
Interventions: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Echocardiography, Fludarabine, Melphalan, Multigated Acquisition Scan, Questionnaire Administration, Tacrolimus, Vedolizumab; Procedure · Drug · Other + 1 more
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Skin Sensitization
Interventions: IV Clear™, Tegaderm CHG™, Silicone Vehicle Control Dressing; Device
Lead sponsor: Covalon Technologies Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Pain, Postoperative
Interventions: DMTS, Placebo; Drug
Lead sponsor: Teikoku Pharma USA, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: Phoenix, Arizona • Bellaire, Texas • San Antonio, Texas + 1 more

Conditions: Hyperprolactinemia, Spontaneous Intracranial Hypotension
Interventions: Pituitary panel will be drawn pre-op and post-op for all patients.; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Port-Wine Stain
Interventions: Cutera excel V™ Laser; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment
Interventions: Perceptual Discrimination Training, Cognitive Control Training; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 79 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Healthy
Interventions: EMSAM (Selegiline Transdermal System) 6mg, EMSAM (Selegiline Transdermal System) 12mg; Drug
Lead sponsor: Somerset Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Rectal Cancer
Interventions: Nitroglycerin 0.2 MG/HR, Nitroglycerin 0.4 MG/HR, Nitroglycerin 0.6 MG/HR; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Carpal Tunnel Syndrome
Interventions: lidocaine patch 5%; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Needle Fear, Vaccine Hesitancy
Interventions: Thimble Application; Device
Lead sponsor: Bianca Edison; Other
Eligibility: 5 Years to 11 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Evaluate the Depth and Duration of Anesthesia

Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness

Smoking Cessation for Depression and Anxiety Treatment

REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)

Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality

Dissemination of Tobacco Tactics for Hospitalized Smokers

Nictavi Tarsus Patch for Managing Lagophthalmos

Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use

Dermal Cryotherapy for Treatment of Pigmented Lesions

Tobacco Treatment Comparison for Cancer Care

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome

Optical Coherence Tomography Guided C&D

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Human Repeat Insult Patch Test of Wound Dressings

Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

Pituitary Function and Spontaneous Intracranial Hypotension

Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser.

NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia

PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Thimble Mindfulness App and Recovery Patch Descriptions